Stroke, Vol 20, 441-447, Copyright © 1989 by American Heart Association
J Biller, A Bruno, HP Adams Jr, JC Godersky, CM Loftus, VL Mitchell, KJ Banwart and MP Jones
In a randomized pilot study we compared the efficacy of temporary
anticoagulation with intravenous heparin sodium to the efficacy of aspirin
in preventing cerebral infarction in hospitalized patients with recent
(less than 7 days) transient ischemic attacks (TIAs). Fifty-five patients
(33 men, 22 women) aged 36-81 (mean 62.7) years met entry criteria and
agreed to participate. Symptoms prompting hospitalization were referable to
the carotid distribution in 43 patients (34 hemispheric, nine retinal); 12
patients had vertebrobasilar distribution TIAs. Twenty-seven patients
received heparin and 28 received aspirin. Patients were treated until
surgery or until long- term medical therapy was instituted, 3-9 (mean 5.5)
days in the heparin group and 3-15 (mean 5.8) days in the aspirin group.
Recurrent TIAs occurred in eight patients given heparin and in seven
treated with aspirin. Infarction occurred in one patient in the heparin
group and in four patients in the aspirin group (three brain, one retinal
infarction). Initial symptoms in these five patients were referable to the
carotid distribution in two and to the vertebrobasilar distribution in
three. All patients but the one with a retinal infarction had recurrent
TIAs prior to stroke. Our pilot study suggests that hospitalized patients
with recent TIAs are at high risk for recurrent TIAs (15 of 55, 27%) and
brain infarction (five of 55, 9%) and that patients with recent
vertebrobasilar distribution TIAs have a marginally significantly higher
risk (odds ratio 6.83, 95% confidence interval 0.65-88.66) of infarction
than patients with recent carotid distribution TIAs.
ARTICLES
A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study
Department of Neurology, University of Iowa College of Medicine, Iowa City.
This article has been cited by other articles:
![]() |
P. Verro Early risk of stroke after transient ischemic attack: back to the future Can. Med. Assoc. J., March 30, 2004; 170(7): 1113 - 1114. [Full Text] [PDF] |
||||
![]() |
S. C. Johnston and J. D. Easton Are Patients With Acutely Recovered Cerebral Ischemia More Unstable? Stroke, October 1, 2003; 34(10): 2446 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Flossmann and P. M. Rothwell Prognosis of vertebrobasilar transient ischaemic attack and minor stroke Brain, September 1, 2003; 126(9): 1940 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Petty, R. D. Brown Jr., J. P. Whisnant, J. D. Sicks, W. M. O'Fallon, and D. O. Wiebers Frequency of Major Complications of Aspirin, Warfarin, and Intravenous Heparin for Secondary Stroke Prevention: A Population-Based Study Ann Intern Med, January 5, 1999; 130(1): 14 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text] |
||||
![]() |
J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |